SciTransfer
Organization

ROLLS-ROYCE SOLUTIONS GMBH

German engine manufacturer specialising in marine propulsion, alternative fuels, and ship retrofitting for zero-emission transport.

Large industrial companytransportDENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€760K
Unique partners
60
What they do

Their core work

Rolls-Royce Solutions GmbH (formerly MTU Friedrichshafen) is a German manufacturer of high-speed diesel and gas engines and power systems, headquartered on Lake Constance. Their core commercial work covers marine propulsion, industrial power generation, and heavy-duty drive systems — making them a direct industrial stakeholder in any project touching ship efficiency, alternative fuels, or transport emissions. In H2020 they contributed engine and propulsion expertise to a large maritime decarbonisation programme, and later appeared as a third-party specialist in a digital health project, likely providing domain knowledge on occupational safety or industrial worker monitoring. As a subsidiary of Rolls-Royce Power Systems, they bring both engineering depth and access to a global industrial supply chain.

Core expertise

What they specialise in

Marine propulsion and ship fuel efficiencyprimary
1 project

Participated as a funded partner in LeanShips (2015–2019), a project targeting low-energy and near-zero emission ships through methanol fuelling and retrofitting.

Alternative maritime fuels (methanol)primary
1 project

LeanShips keywords include methanol, fuel efficiency, retrofitting, and clean transport, pointing to hands-on engine adaptation work for alternative fuel operation.

Industrial occupational health and body-worn sensingemerging
1 project

Contributed as a third party in BIONIC (2019–2022), a personalised body sensor network project for real-time risk assessment in physical work environments.

Clean transport and transport emissions reductionsecondary
1 project

LeanShips positioned the organisation within the EU clean transport agenda, with keywords spanning ecological improvement, green transport, and economic growth from decarbonisation.

Evolution & trajectory

How they've shifted over time

Early focus
Maritime engine decarbonisation and methanol
Recent focus
Digital health and worker body sensing

Their H2020 footprint opens firmly in their core domain: marine engine efficiency, methanol as a ship fuel, and the economic case for retrofitting existing vessels — all classic MTU territory. The single funded project (LeanShips, 2015–2019) reflects an organisation validating real-world engine adaptations against EU clean-shipping targets. The second project (BIONIC, 2019–2022) marks a sharp thematic departure into body sensor networks, GDPR-compliant personal data handling, and age-adapted biomechanical models — a health-and-digital combination with no obvious link to engine manufacturing. Whether this reflects genuine diversification into industrial worker safety or simply a peripheral third-party contribution is unclear from the data alone, but the direction is notable.

Their trajectory suggests cautious exploration of industrial worker health monitoring — a logical adjacency for a large engine manufacturer concerned with operator safety — but the evidence base is thin and the second project's third-party role limits conclusions about strategic commitment.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European15 countries collaborated

MTU has never led a H2020 project — they join as a funded participant or as a third-party expert, indicating a preference for contributing specialist knowledge rather than managing consortia. Their single funded project (LeanShips) placed them inside a large multi-country consortium of 60 partners across 15 countries, which is typical for IA-type shipping projects where OEMs and engine makers sit alongside shipyards, classification societies, and research institutes. Working with them likely means engaging a large corporate partner whose primary motivation is technology validation on real engines, not research output.

Their two projects connect them to 60 unique consortium partners spread across 15 countries — a broad European network for an organisation with only two recorded projects. This reach reflects the large-consortium nature of LeanShips rather than a particularly active partnership strategy.

Why partner with them

What sets them apart

MTU/Rolls-Royce Solutions is one of the very few EU-funded participants who can offer both physical engine hardware and the industrial testing infrastructure to validate alternative fuel concepts at scale — something no university lab or SME can replicate. For consortia building around maritime decarbonisation, retrofitting, or alternative fuels, they bring end-user credibility: results tested on actual MTU engines carry weight with shipowners and classification bodies. Their Rolls-Royce parentage also opens doors to international maritime markets well beyond Europe.

Notable projects

Highlights from their portfolio

  • LeanShips
    Their only funded H2020 project and the clearest expression of their core expertise — methanol propulsion and fuel efficiency retrofitting for commercial ships, backed by EUR 759,710 in EC funding within a 60-partner consortium.
  • BIONIC
    An unexpected sector pivot into personalised body sensor networks and GDPR-compliant health data — notable precisely because it sits entirely outside their engine manufacturing identity, suggesting either industrial safety diversification or a niche third-party contribution.
Cross-sector capabilities
environmenthealthmanufacturing
Analysis note: Only 2 projects across a 7-year span, and the second carries no EC funding and a third-party role — so the profile rests almost entirely on LeanShips. The BIONIC participation is too peripheral to draw firm conclusions about a digital health capability. General knowledge of MTU/Rolls-Royce Solutions as a major engine manufacturer fills gaps the project data cannot, but claims beyond maritime propulsion and alternative fuels should be treated as indicative only.